Mito Health is best for self-directed marker breadth and comparing lab prices across a large menu. Life Extension is best for a big preventive catalog from a brand that also sells supplements. AMORTAL is neither: it takes whichever you pick and turns the results into one ranked next action, a watchlist, and an outcome loop — with restraint built in.
Mito Health and Life Extension are two broad ways to get direct lab access — and they’re built on different bets. Mito leans into self-directed price discovery across a very wide menu: choose what to test (it advertises 1,000+ markers), book nearby labs, compare pricing, and get clinician-reviewed next steps. Life Extension leans into a big preventive, risk-oriented catalog (it advertises 250+ lab tests) from an established brand that’s also a large supplement retailer, so the labs sit inside a broader ecosystem.
Both answer “what can I test, and for how much?” well, in their own way. Neither is built for the harder question that comes next: with a menu that big, what’s actually worth testing, what should a slightly-off marker change, and when do you stop chasing numbers? And with Life Extension, some suggestions sit next to products the same vendor sells. That’s the gap this page is about — and where AMORTAL fits, on top of whichever one you pick. It’s educational, not medical advice.
vs
+
Use Mito Health or Life Extension for breadth and access. Use AMORTAL to decide what's worth testing, what a result should change, and when to stop — vendor-neutral.
The short version: who each is for
Two of these widen access to labs in different ways; the third decides what to do with whichever you have. Here’s the honest split.
Which one fits which job
Mito HealthBest for marker breadth + price discoveryA self-directed testing route: choose what to test from a very wide menu (advertises 1,000+ markers), book nearby labs, and compare pricing, with clinician-reviewed next steps. Strongest when you want breadth and price transparency and you're happy to drive the choices yourself.
Life ExtensionBest for a big catalog + ecosystemA big preventive, risk-oriented blood-test catalog (advertises 250+ lab tests) from an established brand that also sells supplements — labs sit inside a broader ecosystem. Strongest when you want a large, recognisable catalog and don't mind that some suggestions sit next to products the same vendor sells.
AMORTALBest for deciding what to do nextNot a lab. A longitudinal decision layer that reads whatever results you already have — from either provider — and returns one ranked next action, a watchlist, a clinician-ready question, and an outcome loop. Including when to do nothing.
This isn't an "A beats B." Mito and Life Extension both widen access to labs in different ways; AMORTAL answers what should the results change. The strongest setup is one provider plus AMORTAL.
Mito Health vs Life Extension vs AMORTAL, at a glance
Tap between the three to see what each is actually responsible for.
What each one owns
Same goal — better decisions from your labs — split into two ways to access data and one decision layer.
Mito Health — self-directed breadth
A self-directed lab route: choose what to test from a very wide menu (Mito advertises 1,000+ markers), book nearby labs, compare pricing, and get clinician-reviewed next steps.
You want maximum breadth and price transparency and you're comfortable driving the test choices yourself. Verify the current marker menu, lab options and pricing before you buy.
Life Extension — a big catalog + ecosystem
A preventive, risk-oriented blood-testing catalog (Life Extension advertises 250+ lab tests) from an established brand that's also a large supplement retailer, so labs sit alongside products.
You want a big, recognisable catalog and an ecosystem in one place. Verify current tests, pricing and member savings — and note suggestions can sit next to products the same vendor sells.
AMORTAL — the decision layer
Not a lab. It takes either provider's results, normalises them into a memory, and produces one ranked next action, a watchlist, a clinician-ready question, and an outcome loop — vendor-neutral, with restraint built in.
You already have results and the real question is "what now?" — what's worth testing, what to change, what to ignore, and when a retest is actually worth it.
AMORTAL has no direct integration with either — you bring the data in by upload or manual entry.
The comparison, row by row
| Dimension | Mito Health | Life Extension | AMORTAL |
|---|---|---|---|
| Best use case | Self-directed marker breadth + price discovery | Big preventive catalog + supplement ecosystem | Deciding what the data should change |
| Collection method | Choose tests, then book nearby labs yourself (advertised) | Order from the catalog; draw via its network (advertised) | No draws — works from results you have |
| Biomarker breadth | Very wide — advertises 1,000+ markers (verify) | Broad — advertises 250+ lab tests (verify) | Doesn’t test; reads whatever you bring |
| Price discovery | Compare lab pricing across options (advertised) | Catalog pricing + member savings (advertised) | Margin-blind — has no test to sell |
| Wearable integration | Not the core product | Not the core product | Connects labs to Oura / Whoop / Apple Watch |
| Upload existing labs | Its own ordered results | Its own ordered results | Yes — bring either provider’s results in |
| Clinician review | Clinician-reviewed next steps (advertised) | Preventive/risk-oriented testing (advertised) | Clinician-compatible questions; not a clinician |
| Action plan depth | Self-directed; reviewed next steps (advertised) | Guidance alongside a supplement catalog | One ranked next best action, plus restraint |
| Vendor neutrality | Self-directed; not a supplement seller (verify) | Also a large supplement retailer (ecosystem) | Margin-blind; vendor-neutral ranking |
| Retesting cadence | Self-directed; re-order anytime | Catalog cadence + add-ons | Tells you when not to retest yet |
| Result trend tracking | Trends across your Mito orders | Trends across your Life Extension tests | Longitudinal memory across providers and time |
| Abnormal-result handling | Flags + reviewed next steps (advertised) | Preventive flags (as advertised) | Safety-gated; routes urgent flags to a clinician |
| Cost model | Per-test / self-directed (verify current) | Per-test + member pricing (verify current) | Decision layer — founding membership |
| Where AMORTAL fits | Self-directed breadth in | Big catalog data in | → ranked decision, watchlist, outcome loop out |
Provider rows describe what each company publicly advertises as of June 2026 — marker counts, prices, catalog contents and member savings change often, so confirm current details on each provider's own pages before buying. Sources are at the foot of this page.
Which one fits what you actually want
| What you want | Reach for |
|---|---|
| To browse a huge menu and pick my own markers | Mito Health |
| To compare lab pricing before I order | Mito Health |
| A big preventive catalog from one established brand | Life Extension |
| To test and shop supplements in one ecosystem | Life Extension |
| I already have results — tell me what to do next | AMORTAL |
| A vendor-neutral ranking of what’s worth testing or taking | AMORTAL |
| To not chase every slightly-off marker | AMORTAL |
| To know whether I should retest yet | AMORTAL |
| To track whether a protocol actually worked | AMORTAL |
| A clinician-ready question, not a product to buy | AMORTAL |
Where AMORTAL fits — whichever you pick
The model is the same regardless of which route you choose: let the provider do the testing, then run the result through a decision process instead of a dashboard.
- Bring the result in. Upload your Mito Health or Life Extension report, or enter the key markers — there's no direct integration, so you carry the data over.
- Normalise into memory. AMORTAL files each biomarker into a longitudinal record, not a one-off screen.
- Connect the context. Results are linked to your goals, symptoms, wearables, medications and constraints.
- Activate the standards. The guidelines and decision rules that actually apply to your situation switch on.
- Produce a Decision Contract. One change at a time, with the expected signal and the window written down in advance.
- Rank one Next Best Action. Not ten. The single highest-value move — which may be "do nothing yet."
- Set the watchlist. Markers worth re-checking get an expected direction and a recheck window.
- Close the loop. When the next result or outcome signal arrives, AMORTAL checks whether the action worked — and keeps or discards it.
A decision loop, end to end
Here’s the same flow on a single example — illustrative numbers only, not a target or a reference range.
From a result to a tracked outcome
Your Mito Health or Life Extension panel returns a borderline-low vitamin D (say, in a range your clinician flags as worth attention). On a dashboard — or in a catalog that also sells the supplement — the obvious move is to just start buying something.
AMORTAL files it next to your prior results, your goals, your medications and your wearable trends — read as a trajectory, not a single dot, and judged on evidence rather than who's selling the fix.
One lever, not five. The expected signal (vitamin D direction) and the window to see it are written down before anything changes.
Framed as a clinician-ready question — "given this trend, is [one specific lever] the right first move?" — vendor-neutral, and not a treatment or dosing directive AMORTAL has no authority to give.
The marker goes on watch with an expected direction and a recheck window — so you retest when it's informative, not because a wide menu makes it easy to re-order.
At the next draw, AMORTAL checks: did it move as expected? If yes, the change earns its place. If not, it's dropped — no story told over noise, and no slightly-off marker chased for its own sake.
AMORTAL doesn't diagnose and isn't a substitute for your clinician — anything urgent goes to a professional, now.
Are you testing with restraint?
A 1,000+-marker menu and a big catalog make it easy to test everything and chase every slightly-off result. Before you order — or re-order — run yourself through three honest checks. Whichever provider you use, AMORTAL is the layer that sits on top of either.
Are you testing with restraint?
Answer honestly for the panel you're about to order. Disciplined testing should clear all three.
Tick what's true above
Your read on how you're testing appears here.
A guide, not a guarantee. Urgent or critical results always go to a clinician now, whichever provider produced them.
Where each is strongest — and where it isn’t
In fairness to all three:
- Mito Health is strongest when you want maximum breadth and price transparency and you’re happy to drive the test choices yourself — and less ideal if a very wide menu tempts you to test more than you’ll ever act on.
- Life Extension is strongest when you want a big, recognisable preventive catalog and an ecosystem in one place — and less ideal if you’d rather your testing advice didn’t sit next to products the same vendor sells.
- Verify before you buy. Marker menus, prices, catalog contents and member savings change for both — confirm the current details on each provider’s own pages.
- Breadth is a beginning, not an answer. A bigger menu isn’t automatically better; some results will need a clinician, and AMORTAL should never be read as a diagnosis, whichever provider produced the number.
Bring your results into a decision, not a dashboard
AMORTAL doesn’t need to be where you buy your blood tests. The stronger model is to let a provider like Mito Health or Life Extension do the testing, then use AMORTAL as the vendor-neutral decision system around those results. Upload the report, or enter the markers that matter. AMORTAL turns the result into memory, evaluates what’s actually worth testing next, ranks the next best action, sets a watchlist for the signals to expect, and later checks whether the action actually worked — including when the honest answer is to stop.
Already have results from Mito Health or Life Extension? Bring them into AMORTAL and ask the only question that matters: “What should I do next?”
Sources
Provider claims describe what each company publicly advertised when this page was last fact-checked (26 June 2026). Marker menus, pricing, catalog contents and member savings are volatile — verify on the official pages before purchase.
Mito Health — self-directed testing claims: choose what to test, a wide marker menu, nearby lab booking, price comparison and clinician-reviewed next steps.
Life Extension lab testing — preventive, risk-oriented blood-test catalog and member savings, from a brand that also sells supplements.
Educational only — this is not medical advice or a diagnosis. Talk to a licensed clinician about your own numbers, targets, and any treatment decisions.
Frequently asked
Mito Health vs Life Extension — which should I choose?
It depends on what you want from broad lab access. Mito Health is strongest as a self-directed route — choose what to test from a very wide menu (it advertises 1,000+ markers), book nearby labs and compare pricing, with clinician-reviewed next steps. Life Extension is strongest as a big preventive, risk-oriented catalog (it advertises 250+ lab tests) from an established brand that also sells supplements, so labs sit inside a broader ecosystem. Both publish their own menus and pricing, which change often — verify the current details before buying. Whichever you pick, AMORTAL works on top of the results.
Can AMORTAL work with results from either Mito Health or Life Extension?
Yes. AMORTAL is lab-agnostic and works from results you already have — you bring them in by uploading the report or entering key markers (there's no direct integration with either). It normalises the biomarkers into a longitudinal memory, connects them to your goals, wearables and protocols, and returns one ranked next action rather than another dashboard. The provider you chose stays your data source; AMORTAL is the vendor-neutral decision layer.
Does AMORTAL replace Mito Health or Life Extension?
No. They do a different job. Mito Health and Life Extension widen access to lab testing; AMORTAL decides what that data should change, what to ignore, what to watch, and when to retest. Most people who use AMORTAL keep their provider for the testing and use AMORTAL to turn each result into an auditable decision and an outcome loop.
With 1,000+ markers available, should I test as many as I can?
Not automatically. A very wide menu is useful for breadth, but more markers also mean more borderline results that tempt over-reaction and over-testing. AMORTAL evaluates whether a marker would actually change a realistic decision, whether the result is timely, whether a clinician should weigh in, and what downstream signal to watch — and it sets an expected retest window per marker so you re-check when it's informative, not just because the menu makes it easy. Breadth becomes useful instead of noisy.
Life Extension also sells supplements — does that affect its testing advice?
It's worth being aware of. Life Extension is both a lab-testing catalog and a large supplement retailer, so some suggestions can sit next to products the same vendor sells. That doesn't make its testing untrustworthy, but it's exactly why a vendor-neutral second layer helps: AMORTAL is margin-blind — it has no test or supplement to sell — so it ranks what's worth testing or taking on the evidence rather than on who profits from the answer.
I can choose my own tests on Mito Health — what does AMORTAL add?
Self-directed breadth answers 'what can I test?' AMORTAL answers 'what's worth testing, and what should the result change?' It ranks one next best action instead of ten, judges any protocol on evidence rather than on who's selling it, tells you when not to retest yet, and later checks whether the change actually worked — keeping it or discarding it. It's the restraint and outcome-attribution layer on top of however much breadth you choose.